Fiona H. Marshall

14.8k citations

100 papers · 9.3k indexed · 2 hit papers · h-index 53

Molecular Biology top 0.5%
Cellular and Molecular Neuroscience top 0.2%
Radiology, Nuclear Medicine and Imaging top 1%
Physiology top 0.1%
Computational Theory and Mathematics top 0.5%

Co-authors: Miles Congreve A.S. Dore James C. Errey Andrea Bortolato Jonathan S. Mason Malcolm Weir Ali Jazayeri Roger Cooke
Topics: Receptor Mechanisms and Signaling (74 papers)Neuropeptides and Animal Physiology (46 papers)Neuroscience and Neuropharmacology Research (23 papers)
Cited by: Cellular and Molecular Neuroscience Physiology Molecular Biology
Journals: Nature Chemical Reviews Proceedings of the National Academy of Sciences
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Fiona H. Marshall

99 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heterodimerization is required for the formation of a functional GABAB receptor

1998 972 citations Julia H. White, Alan Wise et al. Nature profile →
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation

2022 248 citations Richard J. Mead, Ning Shan et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Fiona H. Marshall

Since Specialization

Citations

This map shows the geographic impact of Fiona H. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona H. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona H. Marshall more than expected).

Fields of papers citing papers by Fiona H. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona H. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona H. Marshall. The network helps show where Fiona H. Marshall may publish in the future.

Co-authorship network of co-authors of Fiona H. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona H. Marshall. A scholar is included among the top collaborators of Fiona H. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona H. Marshall. Fiona H. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translationbreakdown → 2022 ·Nature Reviews Drug Discovery ·Richard J. Mead,Ning Shan,(unknown),Fiona H. Marshall,Pamela J. Shaw	248
2	Targeting impaired adult hippocampal neurogenesis in ageing by leveraging intrinsic mechanisms regulating Neural Stem Cell activity 2021 ·Ageing Research Reviews ·Sébastien Gillotin,(unknown),(unknown),(unknown),Jina Swartz,Zoi Alexopoulou,Fiona H. Marshall	22
3	Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals 2018 ·Scientific Reports ·Prakash Rucktooa,R.K. Cheng,Elena Segala,Tian Geng,James C. Errey,Giles A. Brown,Roger Cooke,Fiona H. Marshall,A.S. Dore	69
4	Erratum: Opportunities for therapeutic antibodies directed at G-protein-coupled receptors 2017 ·Nature Reviews Drug Discovery ·Catherine J. Hutchings,Markus Koglin,William C. Olson,Fiona H. Marshall	36
5	Crystal structure of the GLP-1 receptor bound to a peptide agonist 2017 ·Nature ·Ali Jazayeri,Mathieu Rappas,Alastair Brown,James Kean,James C. Errey,N.J. Robertson,Cédric Fiez-Vandal,Stephen P. Andrews,Miles Congreve,Andrea Bortolato,Jonathan Mason,Asma Baig,Iryna Teobald,A.S. Dore,Malcolm Weir,Roger Cooke,Fiona H. Marshall	136
6	Intracellular allosteric antagonism of the CCR9 receptor 2016 ·Nature ·Christine Oswald,Mathieu Rappas,James Kean,A.S. Dore,James C. Errey,K.A. Bennett,Francesca Deflorian,J.A. Christopher,Ali Jazayeri,Jonathan S. Mason,Miles Congreve,Roger Cooke,Fiona H. Marshall	196
7	Biophysical Fragment Screening of the β ₁ -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design 2013 ·Journal of Medicinal Chemistry ·J.A. Christopher,Jason Brown,A.S. Dore,James C. Errey,Markus Koglin,Fiona H. Marshall,David G. Myszka,Rebecca L. Rich,Christopher G. Tate,Benjamin G. Tehan,Tony Warne,Miles Congreve	123
8	Insights into the structure of class B GPCRs 2013 ·Trends in Pharmacological Sciences ·Kaspar Hollenstein,Chris de Graaf,Andrea Bortolato,Ming‐Wei Wang,Fiona H. Marshall,Raymond C. Stevens	178
9	Fragment Screening of Stabilized G-Protein-Coupled Receptors Using Biophysical Methods 2011 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Miles Congreve,Rebecca L. Rich,David G. Myszka,(unknown),Gregg Siegal,Fiona H. Marshall	86
10	Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine 2011 ·Structure ·A.S. Dore,N.J. Robertson,James C. Errey,Irene W. Ng,Kaspar Hollenstein,B.G. Tehan,Edward Hurrell,K.A. Bennett,Miles Congreve,Francesca Magnani,Christopher G. Tate,Malcolm Weir,Fiona H. Marshall	453
11	The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery 2010 ·Neuropharmacology ·N.J. Robertson,Ali Jazayeri,James C. Errey,Asma Baig,Edward Hurrell,Andrei Zhukov,Christopher J. Langmead,Malcolm Weir,Fiona H. Marshall	126
12	Atomoxetine produces changes in cortico-basal thalamic loop circuits: Assessed by phMRI BOLD contrast 2006 ·Neuropharmacology ·Neil Easton,Fiona H. Marshall,K.C.F. Fone,C.A. Marsden	26
13	Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast 2006 ·Psychopharmacology ·Neil Easton,Yasmene B. Shah,Fiona H. Marshall,K.C.F. Fone,C.A. Marsden	27
14	GABAB receptor subunits, R1 and R2, in brainstem catecholamine and serotonin neurons 2003 ·Brain Research ·Kathleen J. Burman,(unknown),Julia H. White,Fiona H. Marshall,Menelas N. Pangalos,Piers C. Emson,Jane Minson,Ida J. Llewellyn‐Smith	28
15	Heterodimerization of G-protein-coupled receptors in the CNS 2001 ·Current Opinion in Pharmacology ·Fiona H. Marshall	41
16	Protein-Protein Interaction and Not Glycosylation Determines the Binding Selectivity of Heterodimers between the Calcitonin Receptor-like Receptor and the Receptor Activity-modifying Proteins 2001 ·Journal of Biological Chemistry ·Sandrine Hilairet,Steven M. Foord,Fiona H. Marshall,Michel Bouvier	92
17	Characterization of [³H]‐CGP54626A binding to heterodimeric GABA_B receptors stably expressed in mammalian cells 2000 ·British Journal of Pharmacology ·Andrew Green,(unknown),Alan Wise,Richard H. Green,(unknown),Fiona H. Marshall	33
18	A Bioluminescent Assay for Agonist Activity at Potentially Any G-Protein-Coupled Receptor 1997 ·Analytical Biochemistry ·Jenny Stables,Andrew R. Green,Fiona H. Marshall,Neil J. Fraser,(unknown),Martine Sautel,Graeme Milligan,Melanie Lee,(unknown)	181
19	Temperature and agonist dependency of tachykinin NK1 receptor antagonist potencies in rat isolated superior cervical ganglion 1995 ·European Journal of Pharmacology ·A.B. Hawcock,I.J.M. Beresford,Fiona H. Marshall,Russell M. Hagan	7
20	Pharmacological profile of GR117289 in vitro: a novel, potent and specific non‐peptide angiotensin AT₁ receptor antagonist 1992 ·British Journal of Pharmacology ·Mark J. Robertson,Jen Barnes,G.M. Drew,Kenneth L. Clark,Fiona H. Marshall,A.D. Michel,David Middlemiss,Barry C. Ross,D. I. C. SCOPES,Michael D. Dowle	66

About Fiona H. Marshall

Fiona H. Marshall is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology, having authored 100 papers that have together received 9.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (74 papers), Neuropeptides and Animal Physiology (46 papers) and Neuroscience and Neuropharmacology Research (23 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (4.7k citations), Physiology (923 citations) and Molecular Biology (7.0k citations). Fiona H. Marshall has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Miles Congreve, A.S. Dore, James C. Errey, Andrea Bortolato, Jonathan S. Mason, Malcolm Weir, Ali Jazayeri, Roger Cooke, Alan Wise and Steven M. Foord. Their work appears in journals such as Nature, Chemical Reviews and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact